GGrantIndex
Sort

4,870 grants matching glp 1

Hematopoietic Biorepository and Cellular Therapy Shared Resource

$125,198
David Wald · Case Western Reserve University · P30 · FY2018 · CA

3-Month Toxicity and Toxicokinetics Intravenous Infusion Study in Beagle Dogs Giv

$125,000
Dmytro Berezhnoy · Ogenx Therapeutics Corporation · R01 · FY2014 · FD

RNA recognition by maternal gene silencers in nematodes

$124,975
Sean Patrick Ryder · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · GM

Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation

$124,800
Xiaojuan Li · Harvard Pilgrim Health Care, Inc. · K01 · FY2024 · AG

Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation

$124,732
Xiaojuan Li · Harvard Pilgrim Health Care, Inc. · K01 · FY2022 · AG

Optimizing care for older adults in the new treatment era for type 2 diabetes and heart failure: Strengthening causal inference through novel approaches and evidence triangulation

$124,610
Xiaojuan Li · Harvard Pilgrim Health Care, Inc. · K01 · FY2023 · AG

Ph2.Study of PAT-001 for Treatment of Congenital Ichthyosis IND122058(7/27/2016)

$124,519
Zachary Rome · Timber Pharmaceuticals, Llc · R01 · FY2021 · FD

Analytical Pharmacology

$124,437
Timothy W Synold · Beckman Research Institute/City Of Hope · P30 · FY2024 · CA

"Subunit Vaccines for Brucella Pathogens"

$124,335
David W Pascual · Montana State University - Bozeman · R01 · FY2012 · AI

Optimizing diabetes treatment strategies in complex comorbidity

$123,358
Amanda Candice Leiter · Icahn School Of Medicine At Mount Sinai · K08 · FY2025 · DK

Clinical Pharmacology Shared Resource

$123,283
Paul Toren · University Of Kansas Medical Center · P30 · FY2021 · CA

Obesity induced cytokines and beta cell mass regulation

$123,060
Amelia K Linnemann · University Of Wisconsin-Madison · K01 · FY2015 · DK

Clinical Pharmacology Shared Resource

$122,960
Gregory Allen Reed · University Of Kansas Medical Center · P30 · FY2018 · CA

Immunological monitoring and cellular products laboratory

$122,920
Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · NS

Etiology of Impaired Counterregulation in Glucose Homeostasis: Exploring the Roles of Glucagon, Somatostatin, Cortisol, and Epinephrine through Mathematical Modeling of Oral Glucose Tolerance Tests

$122,591
Vijaya Subramanian · Johns Hopkins University · K25 · FY2025 · DK

Etiology of Impaired Counterregulation in Glucose Homeostasis: Exploring the Roles of Glucagon, Somatostatin, Cortisol, and Epinephrine through Mathematical Modeling of Oral Glucose Tolerance Tests

$122,591
Vijaya Subramanian · Johns Hopkins University · K25 · FY2023 · DK

Etiology of Impaired Counterregulation in Glucose Homeostasis: Exploring the Roles of Glucagon, Somatostatin, Cortisol, and Epinephrine through Mathematical Modeling of Oral Glucose Tolerance Tests

$122,591
Vijaya Subramanian · Johns Hopkins University · K25 · FY2024 · DK

Glucagon-like peptide-1 modulation of alcohol effects

$122,522
Morgane Hermann Thomsen · Region Hovedstaden · R01 · FY2020 · AA

Immunological monitoring and cellular products laboratory

$122,342
Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2011 · NS

Immune Monitoring and BiKE Production Core

$122,278
Michael R Verneris · University Of Minnesota · P01 · FY2016 · CA

Immune Monitoring and BiKE Production Core

$122,025
Michael R Verneris · University Of Minnesota · P01 · FY2020 · CA

Hematopoietic Biorepository and Cellular Therapy Shared Resource

$121,991
David Wald · Case Western Reserve University · P30 · FY2019 · CA

Investigations of botanicals on food intake, satiety, weight loss, and oxidative

$121,787
Stephen D Anton · University Of Florida · K23 · FY2012 · AT

Glucagon-like peptide-1 modulation of alcohol effects

$121,272
Morgane Hermann Thomsen · Region Hovedstaden · R01 · FY2021 · AA

Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children

$120,938
Will Clifton · Polyvascular Corporation · R44 · FY2022 · HL